Scalability of effective adherence interventions for patients using cardiovascular disease medication: A realist synthesis-inspired systematic review
- PMID: 35617955
- DOI: 10.1111/bcp.15418
Scalability of effective adherence interventions for patients using cardiovascular disease medication: A realist synthesis-inspired systematic review
Erratum in
-
Correction to "Scalability of effective adherence interventions for patients using cardiovascular disease medication: A realist synthesis-inspired systematic review".Br J Clin Pharmacol. 2023 Sep;89(9):2939. doi: 10.1111/bcp.15837. Epub 2023 Jul 4. Br J Clin Pharmacol. 2023. PMID: 37401766 No abstract available.
Abstract
Upscaling of medication adherence interventions to routine care is still challenging. This realist theory-inspired review aimed to assess which intervention aspects are potentially important for the scalability of effective cardiovascular disease (CVD) medication adherence interventions and how they are reported in effectiveness studies. A total of 4097 articles from four databases were screened of which ultimately 31 studies were included. Relevant information on scalability was extracted using a theoretic framework based on the scalability assessment tool used in the QUALIDEC study for the following domains: (i) innovation, (ii) implementers and patients, (iii) adopting organizations and health system, and (iv) socio-political context. Extracted articles were analysed for themes and chains of inference, which were grouped based on commonality and source of evidence to form new hypotheses. Six different domains relevant for scalability of adherence interventions were identified: (1) Complexity of the intervention; (2) training; (3) customization of the intervention; (4) drivers of the intervention; (5) technical interventions; and (6) stakeholder involvement. These six domains might be useful for the development of more scalable interventions by bridging the gap between research and practice. Data relevant for scalability is not well reported on in effectiveness trials for CVD medication adherence interventions and only limited data on scalability has been published in additional papers. We believe the adoption and reach of effective CVD medication adherence interventions will improve with increased awareness for the necessity of scalability in all phases of intervention development.
Keywords: adherence; cardiovascular; clinical pharmacology; primary care; realist synthesis.
© 2022 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
References
REFERENCES
-
- WHO. (2021). Cardiovascular diseases (CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases.... Published June 11, 2021. Accessed May 31, 2022.
-
- Ferdinand KC, Senatore FF, Clayton-Jeter H, et al. Improving medication adherence in cardiometabolic disease. J Am Coll Cardiol. 2017;69(4):437-451. doi:10.1016/j.jacc.2016.11.034
-
- Kronish IM, Ye S. Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis. 2013;55(6):590-600. doi:10.1016/j.pcad.2013.02.001
-
- Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940-2948. doi:10.1093/eurheartj/eht295
-
- Leslie KH, McCowan C, Pell JP. Adherence to cardiovascular medication: a review of systematic reviews. J Public Health (Oxf). 2019;41(1):e84-e94. doi:10.1093/pubmed/fdy088
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
